Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation

Part of paid clinical trials in Duarte, California.

Sponsor
Fred Hutchinson Cancer Center
Study ID
NCT00045292
Phase
PHASE3
Status
Completed

Conditions

  • Cancer

Eligibility Criteria

Sex
ALL
Age
12 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • acyclovir — DRUG
  • acyclovir sodium — DRUG
  • valacyclovir — DRUG

Study Details

RATIONALE: Antivirals such as valacyclovir act against viruses and may be effective in preventing cytomegalovirus. It is not yet known if valacyclovir is effective in preventing cytomegalovirus in patients undergoing stem cell transplantation. PURPOSE: Randomized phase III trial to determine the effectiveness of valacyclovir in preventing cytomegalovirus in patients who are undergoing donor stem cell transplantation.

Key Dates

Start date
Apr 30, 2002
Status verified
Sep 2010
Completion
Oct 31, 2004

Study Design

Allocation
RANDOMIZED
Primary purpose
SUPPORTIVE_CARE

Locations (6)

FacilityCityStateZIPSite coordinators
City of Hope Comprehensive Cancer CenterDuarteCalifornia91010-3000-
Stanford Cancer Center at Stanford University Medical CenterStanfordCalifornia94305-
UNMC Eppley Cancer Center at the University of Nebraska Medical CenterOmahaNebraska68198-3330-
Baylor University Medical CenterDallasTexas75246-
Huntsman Cancer InstituteSalt Lake CityUtah84132-
Fred Hutchinson Cancer Research CenterSeattleWashington98109-1024-

Find similar trials in Duarte, CA

By research site
City of Hope Comprehensive Cancer Center· Duarte, CAStanford Cancer Center at Stanford University Medical Center· Stanford, CAUNMC Eppley Cancer Center at the University of Nebraska Medical Center· Omaha, NEBaylor University Medical Center· Dallas, TXHuntsman Cancer Institute· Salt Lake City, UTFred Hutchinson Cancer Research Center· Seattle, WA

Related Studies